OrbiMed’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-551,500
| Closed | -$12.4M | – | 139 |
|
2016
Q4 | $12.4M | Buy |
551,500
+180,600
| +49% | +$4.05M | 0.16% | 81 |
|
2016
Q3 | $8.42M | Hold |
370,900
| – | – | 0.1% | 102 |
|
2016
Q2 | $8.75M | Sell |
370,900
-467,200
| -56% | -$11M | 0.09% | 95 |
|
2016
Q1 | $17.1M | Sell |
838,100
-463,600
| -36% | -$9.46M | 0.18% | 66 |
|
2015
Q4 | $67M | Buy |
1,301,700
+317,000
| +32% | +$16.3M | 0.61% | 46 |
|
2015
Q3 | $42M | Buy |
984,700
+134,000
| +16% | +$5.71M | 0.42% | 48 |
|
2015
Q2 | $38.7M | Hold |
850,700
| – | – | 0.32% | 61 |
|
2015
Q1 | $32.3M | Hold |
850,700
| – | – | 0.28% | 62 |
|
2014
Q4 | $24.1M | Hold |
850,700
| – | – | 0.23% | 65 |
|
2014
Q3 | $21.5M | Sell |
850,700
-510,900
| -38% | -$12.9M | 0.22% | 68 |
|
2014
Q2 | $39.7M | Buy |
1,361,600
+403,900
| +42% | +$11.8M | 0.47% | 47 |
|
2014
Q1 | $24.8M | Hold |
957,700
| – | – | 0.31% | 55 |
|
2013
Q4 | $24.7M | Buy |
957,700
+630,700
| +193% | +$16.2M | 0.36% | 55 |
|
2013
Q3 | $8.75M | Sell |
327,000
-153,319
| -32% | -$4.1M | 0.16% | 72 |
|
2013
Q2 | $11.8M | Buy |
+480,319
| New | +$11.8M | 0.25% | 63 |
|